Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Strongyle Infections, Equine D013319 1 associated lipids
Basal Ganglia Hemorrhage D020145 1 associated lipids
Edema, Cardiac D004489 1 associated lipids
Osteoblastoma D018215 1 associated lipids
Radiculopathy D011843 1 associated lipids
Oligomenorrhea D009839 1 associated lipids
Erythromelalgia D004916 1 associated lipids
Intracranial Hemorrhage, Hypertensive D020299 1 associated lipids
Cholecystitis, Acute D041881 1 associated lipids
Bluetongue D001819 1 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Best LC et al. The interrelationship between thromboxane biosynthesis, aggregation and 5-hydroxytryptamine secretion in human platelets in vitro. 1980 Thromb. Haemost. pmid:6773171
Greer IA et al. A comparative study of the effects of adrenoceptor antagonists on platelet aggregation and thromboxane generation. 1985 Thromb. Haemost. pmid:2867620
Santilli F et al. Effects of high-amount-high-intensity exercise on in vivo platelet activation: modulation by lipid peroxidation and AGE/RAGE axis. 2013 Thromb. Haemost. pmid:24030807
di Minno G et al. Effects of any epoxymethano stable analogue of prostaglandin endoperoxides (U-46619) on human platelets. 1981 Thromb. Haemost. pmid:6266066
Siess W et al. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation. 1981 Thromb. Haemost. pmid:7025338
Watanabe J et al. Effect of vitamin E on platelet aggregation in diabetes mellitus. 1984 Thromb. Haemost. pmid:6495252
Honey AC et al. Effect of indomethacin and dazoxiben on intravascular platelet aggregation in the anaesthetized rabbit. 1986 Thromb. Haemost. pmid:3775692
Kyrle PA et al. Investigation of the interaction of blood platelets with the coagulation system at the site of plug formation in vivo in man--effect of low-dose aspirin. 1987 Thromb. Haemost. pmid:2954260
Chen SL et al. Chlorobutanol, a preservative of desmopressin, inhibits human platelet aggregation and release in vitro. 1990 Thromb. Haemost. pmid:2096493
Larson MK et al. Effects of omega-3 acid ethyl esters and aspirin, alone and in combination, on platelet function in healthy subjects. 2008 Thromb. Haemost. pmid:18841286
Vejar M et al. Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina. 1990 Thromb. Haemost. pmid:2363117
Dragani A et al. Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→T polymorphism. 2012 Thromb. Haemost. pmid:22782530
Vezza R et al. Antivasoconstrictor and antiaggregatory activities of picotamide unrelated to thromboxane A2 antagonism. 1997 Thromb. Haemost. pmid:9408024
Greer IA et al. Platelet activation in allergic asthma. 1985 Thromb. Haemost. pmid:2931855
Wang JS et al. Effect of strenuous arm exercise on oxidized-LDL-potentiated platelet activation in individuals with spinal cord injury. 2000 Thromb. Haemost. pmid:10928481
Subbiah MT et al. Studies of aggregation and thromboxane B2 synthesis in avian thrombocytes: comparison between atherosclerosis-susceptible and resistant breeds. 1980 Thromb. Haemost. pmid:7455983
Zahavi M et al. Abnormal typical pattern of platelet function and thromboxane generation in unstable angina. 1989 Thromb. Haemost. pmid:2531938
Patrono C et al. Characterization of biochemical and functional effects of antiplatelet drugs as a key to their clinical development. 1995 Thromb. Haemost. pmid:8578493
Fruzzetti F et al. Platelet-vessel wall interactions with third-generation oral contraceptives: no evidence of detrimental effects. 1999 Thromb. Haemost. pmid:10494782
Zahavi J and Zahavi M Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease. 1985 Thromb. Haemost. pmid:3158092
Etulain J et al. Acidosis downregulates platelet haemostatic functions and promotes neutrophil proinflammatory responses mediated by platelets. 2012 Thromb. Haemost. pmid:22159527
Pettinella C et al. Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. 2009 Thromb. Haemost. pmid:19350112
Korbut R et al. On the mechanism of thrombolytic action of thromboxane synthetase inhibitors. 1987 Thromb. Haemost. pmid:3324381
Kyrle PA et al. Evidence for an increased generation of prostacyclin in the microvasculature and an impairment of the platelet alpha-granule release in chronic renal failure. 1988 Thromb. Haemost. pmid:2975407
McMahon GS et al. Transient heparin-induced platelet activation linked to generation of platelet 12-lipoxygenase. Findings from a randomised controlled trial. 2013 Thromb. Haemost. pmid:23494053
Larsen SB et al. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease. 2013 Thromb. Haemost. pmid:23407706
De Caterina R et al. Equal antiplatelet effects of aspirin 50 or 324 mg/day in patients after acute myocardial infarction. 1985 Thromb. Haemost. pmid:4082090
Montuschi P et al. Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD. 2005 Thorax pmid:16192367
Rodwell LT et al. Effect of inhaled frusemide and oral indomethacin on the airway response to hypertonic saline challenge in asthmatic subjects. 1997 Thorax pmid:9039247
Montuschi P et al. Exhaled leukotrienes and prostaglandins in COPD. 2003 Thorax pmid:12832671
Picado C et al. Effects of a fish oil enriched diet on aspirin intolerant asthmatic patients: a pilot study. 1988 Thorax pmid:3353894
Dapper F et al. Effects of pulsatile and nonpulsatile perfusion mode during extracorporeal circulation--a comparative clinical study. 1992 Thorac Cardiovasc Surg pmid:1290181
Zhou JA et al. The effects of dauricine and verapamil as calcium channel blockers on the plasma concentration of 6-keto-prostaglandin F1 alpha and thromboxane B2 during cardiopulmonary bypass. 1987 Thorac Cardiovasc Surg pmid:2442837
Kobinia GS et al. Influence of coronary artery obstruction on cardiac prostaglandin metabolism during experimental cardioplegic arrest. 1986 Thorac Cardiovasc Surg pmid:2424127
Pradalier A et al. [Measurement of plasma and serum values of PGE2, PGF2 alpha and TXB2 during aspirin induced bronchospasm in asthmatics (author's transl)]. 1979 Jul-Aug Therapie pmid:531778
Oelz O [The arachidonic acid metabolites (prostaglandins, thromboxanes, prostacyclin, leucotrienes):basics and clinical implications (author's transl)]. 1979 Ther Umsch pmid:119331
Morris HG et al. Effects of salsalate (nonacetylated salicylate) and aspirin on serum prostaglandins in humans. 1985 Ther Drug Monit pmid:3866409
Semenov AV et al. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension]. 2000 Ter. Arkh. pmid:10833791
Iagoda AV and Gladkikh NN [Thromboxane-prostacyclin balance and platelet aggregability in patients with minor cardiac abnormalities]. 2010 Ter. Arkh. pmid:21086621
Rud'ko IA et al. [The level of thromboxane A2 and prostacyclin in patients with chronic kidney failure undergoing hemodialysis]. 1991 Ter. Arkh. pmid:1948751
Chen YC et al. Studies of platelet hyperactivity in patients with ischemic cerebrovascular diseases: IV. Determination of the optimal dosage of aspirin by measuring plasma salicylate level. 1987 Taiwan Yi Xue Hui Za Zhi pmid:3694163
Liu MC et al. Studies of platelet hyperactivity in patients with ischemic cerebrovascular diseases. III. Platelet hyperactivation in the chronic phase of cerebral thromboembolism. 1985 Taiwan Yi Xue Hui Za Zhi pmid:3160819
Ding YA et al. Effects of exercise and ticlopidine on platelet function and prostanoids in patients with old myocardial infarction. 1989 Taiwan Yi Xue Hui Za Zhi pmid:2592938
Demling RH and Lalonde C Topical ibuprofen decreases early postburn edema. 1987 Surgery pmid:3672325
VanderMeer TJ et al. Protective effects of a novel 32-amino acid C-terminal fragment of CAP18 in endotoxemic pigs. 1995 Surgery pmid:7778029
Slotman GJ et al. Thromboxane A2 mediates hemodynamic and respiratory dysfunction in graded bacteremia. 1986 Surgery pmid:3526603
Addonizio VP et al. Prevention of heparin-induced thrombocytopenia during open heart surgery with iloprost (ZK36374). 1987 Surgery pmid:2445042
Demling RH et al. Comparison of the postburn hyperdynamic state and changes in lung function (effect of wound bacterial content). 1986 Surgery pmid:3535145
Demling RH et al. The pulmonary and systemic response to recurrent endotoxemia in the adult sheep. 1986 Surgery pmid:3535147
Kirton OC et al. The development of a model of subacute lung injury after intra-abdominal infection. 1984 Surgery pmid:6379962
Lelcuk S et al. Nicotine stimulates pulmonary parenchymal thromboxane synthesis. 1986 Surgery pmid:3775653
Cooper JD et al. Prostaglandin production associated with the pulmonary vascular response to complement activation. 1980 Surgery pmid:7394704
Nerlich M et al. Effect of thermal injury on endotoxin-induced lung injury. 1983 Surgery pmid:6337423
Huval WV et al. Thromboxane mediation of cardiovascular dysfunction following aspiration. 1983 Surgery pmid:6308843
Demling RH et al. The immediate effect of burn wound excision on pulmonary function in sheep: the role of prostanoids, oxygen radicals, and chemoattractants. 1987 Surgery pmid:3798327
Paterson IS et al. Thromboxane mediates the ischemia-induced neutrophil oxidative burst. 1989 Surgery pmid:2527418
Lelcuk S et al. Prostacyclin and thromboxane A2 moderate postischemic renal failure. 1985 Surgery pmid:3895535
Farias LR et al. Effect of prostaglandin blockers on ascites fluid in pancreatitis. 1985 Surgery pmid:3898455
Klausner JM et al. Oxygen free radicals mediate ischemia-induced lung injury. 1989 Surgery pmid:2536967
Demling RH et al. The lung inflammatory response to thermal injury: relationship between physiologic and histologic changes. 1989 Surgery pmid:2500726
Sell LL et al. Hypertension during extracorporeal membrane oxygenation: cause, effect, and management. 1987 Surgery pmid:2821641
Klausner JM et al. Interleukin-2-induced lung injury is mediated by oxygen free radicals. 1991 Surgery pmid:1899491
Goldman G et al. Leukocytes mediate acid aspiration-induced multiorgan edema. 1993 Surgery pmid:8395089
Wong C et al. Effect of hydroxyl radical scavenging on endotoxin-induced lung injury. 1985 Surgery pmid:2983450
Slotman GJ et al. Interaction of prostaglandins, activated complement, and granulocytes in clinical sepsis and hypotension. 1986 Surgery pmid:3520916
Hanazaki K et al. Protective effect of the thromboxane A2 receptor antagonist ONO 3708 on ischemia-reperfusion injury in the dog liver. 1994 Surgery pmid:7940195
Ichihara T et al. The effects of using a leukocyte removal filter during cold blood cardioplegia. 1994 Surg. Today pmid:7772907
Iwata M Pathophysiology of dogs after 84% hepatectomy with emphasis on prostaglandin metabolites and the effect of a thromboxane A2 synthesis inhibitor and a prostaglandin I2 analog. 1994 Surg. Today pmid:7780227
Isozaki H et al. The protective effect of thromboxane A2 synthetase inhibitor against ischemic liver injury. 1994 Surg. Today pmid:8054815
Isozaki H et al. Urinary thromboxane B2 as an indicator of acute rejection in human liver transplantation. 1996 Surg. Today pmid:8727944
Kitagawa M et al. The role of the spleen, especially regarding changes in both thromboxane A2 and the remnant liver dysfunction after extensive hepatectomy. 1999 Surg. Today pmid:10030738
Itasaka H et al. The mechanism of hepatic graft protection against reperfusion injury by prostaglandin E1. 1999 Surg. Today pmid:10385367
Onizuka M et al. Suppression of prostanoid formation and regulation of peripheral circulation after surgery using thrombin inhibitor (MD805). 1998 Surg. Today pmid:9681611
Yang SY and Gao ZX Determination and clinical significance of plasma levels of prostaglandins in patients with acute brain injury. 1999 Surg Neurol pmid:10511080
Seifert V et al. Arachidonic acid metabolism following aneurysm rupture. Evaluation of cerebrospinal fluid and serum concentration of 6-keto-prostaglandin F1 alpha and thromboxane B2 in patients with subarachnoid hemorrhage. 1987 Surg Neurol pmid:3810456
Kaufman RP et al. A high plasma prostaglandin to thromboxane ratio protects against renal ischemia. 1987 Surg Gynecol Obstet pmid:3672299
Ferraris VA and Swanson E Aspirin usage and perioperative blood loss in patients undergoing unexpected operations. 1983 Surg Gynecol Obstet pmid:6836459
Utsunomiya T et al. Treatment of pulmonary embolism with positive end-expiratory pressure and prostaglandin E1. 1981 Surg Gynecol Obstet pmid:7017981
Rabinovici R et al. Hemodynamic, hematologic and eicosanoid mediated mechanisms in 7.5 percent sodium chloride treatment of uncontrolled hemorrhagic shock. 1992 Surg Gynecol Obstet pmid:1411892
Mathieson MA et al. Ischemia of the limb stimulates thromboxane production and myocardial depression. 1983 Surg Gynecol Obstet pmid:6648769
Manny J et al. Pulmonary and systemic consequences of localized acid aspiration. 1986 Surg Gynecol Obstet pmid:3952619
Reines HD et al. Lack of effect of glucocorticoids upon plasma thromboxane in patients in a state of shock. 1985 Surg Gynecol Obstet pmid:3983796
Davies GC et al. Thromboxane B2 and fibrinopeptide A levels in platelet consumption and thrombosis. 1978 Surg Forum pmid:401227
Tohgi H et al. Individual variation in platelet aggregability and serum thromboxane B2 concentrations after low-dose aspirin. 1988 Stroke pmid:3376161
Patrono C et al. Thromboxane biosynthesis in cardiovascular diseases. 1990 Stroke pmid:2260137
Juvela S et al. Platelet thromboxane release after subarachnoid hemorrhage and surgery. 1990 Stroke pmid:2326838
Tohgi H et al. Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin. 1992 Stroke pmid:1412574
Minamisawa H et al. Brain eicosanoid levels in spontaneously hypertensive rats after ischemia with reperfusion: leukotriene C4 as a possible cause of cerebral edema. 1988 Stroke pmid:3354024
Pettigrew LC et al. Effect of thromboxane synthase inhibition on eicosanoid levels and blood flow in ischemic rat brain. 1989 Stroke pmid:2718203
Vicari AM et al. Platelet function and thrombin activity in patients with recent cerebral transient ischemic attacks. 1987 Sep-Oct Stroke pmid:2957821
Cox D et al. Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers. 2006 Stroke pmid:16794200
Hanamura T et al. Prostaglandin profiles in relation to local circulatory changes following focal cerebral ischemia in cats. 1989 Stroke pmid:2728049
Shohami E et al. The effect of incomplete cerebral ischemia on prostaglandin levels in rat brain. 1982 Jul-Aug Stroke pmid:6896589
Sirén AL et al. Release of proinflammatory and prothrombotic mediators in the brain and peripheral circulation in spontaneously hypertensive and normotensive Wistar-Kyoto rats. 1992 Stroke pmid:1440713
Numminen H et al. The effect of acute ingestion of a large dose of alcohol on the hemostatic system and its circadian variation. 2000 Stroke pmid:10835443
van Kooten F et al. Increased platelet activation in the chronic phase after cerebral ischemia and intracerebral hemorrhage. 1999 Stroke pmid:10066850
van Kooten F et al. Evidence for episodic platelet activation in acute ischemic stroke. 1994 Stroke pmid:8303731
Fisher M and Zipser R Increased excretion of immunoreactive thromboxane B2 in cerebral ischemia. 1985 Jan-Feb Stroke pmid:3966251
van Kooten F et al. Increased thromboxane biosynthesis is associated with poststroke dementia. 1999 Stroke pmid:10436098
Gonzalez-Conejero R et al. Biological assessment of aspirin efficacy on healthy individuals: heterogeneous response or aspirin failure? 2005 Stroke pmid:15604423